Novartis Sues Cipla Over Respiratory Drug

Mumbai: Swiss drug maker Novartis AG said on Wednesday it had sued Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price. Cipla, India's fourth-largest drug maker by revenue, launched its copy of Onbrez in New Delhi in October, citing urgent unmet need for the drug in the country. "There is an ample supply of Onbrez, and Cipla's claim...